Middle East & Africa Structural Heart Market

The Middle East & Africa structural heart market is expected to grow from US$ 643.90 million in 2022 to US$ 927.25 million by 2028. It is estimated to grow at a CAGR of 6.3% from 2022 to 2028.

Growing Use of Artificial Intelligence in Structural Heart Fuel Middle East & Africa Structural Heart Market

The number of interventional structural heart disease (SHD) procedures, such as transcatheter valve procedures, has increased significantly in recent years, triggering the need for well-founded knowledge about optimal anatomical spatial orientation during these procedures. This has led to the development of new procedural capabilities and technologies in periprocedural planning. Hybrid fusion imaging (FI) combines multiple imaging modalities, mainly based on multislice spiral computed tomography (MSCT) and echocardiography, with fluoroscopy. Ongoing developments in machine learning and artificial intelligence (AI) facilitate the routine use of individualized segmented 3D heart models that allow for multiple combinations of different imaging modalities. As AI enables computers to perform tasks at a greater speed and with potentially better precision than humans, risk stratification and outcome aspects can be optimized in the future. The application of computer modeling, 3D printing, and AI has already led to transformations in procedure planning and physician education on SHD. These technologies also promise unlimited possibilities. With further research and development, AI can advance precision medicine at every step, including diagnosis, treatment stratification and device selection, procedure delivery and guidance, and post-procedure/discharge monitoring and rehabilitation. The prevalence of cardiovascular diseases is rising worldwide. The structural heart market is at the initial stage of development in regions such as the Middle East and Africa.

Most of the people in this region chew or smoke tobacco, and the incidence of structural heart disease is increasing in this region. According to the American Heart, cardiovascular diseases caused ~19.1 million deaths worldwide in 2020. Thus, with the rising incidence of structural heart diseases in the abovementioned regions, the market players are likely to grab significant opportunities to offer effective products.

Middle East & Africa Structural Heart Market Overview

The Middle East & Africa structural heart market is estimated to grow at a CAGR of 6.3% from 2022 to 2028. Key factors driving the market growth are availability of innovative structural heart services and rise in the number of cardiovascular diseases and training programs. However, high cost of procedure followed by stringent regulations regarding structure heart device are the major factors hampering the growth of the market.

Middle East & Africa Structural heart Market Revenue and Forecast to 2028

Middle East & Africa Structural Heart Strategic Insights

Strategic insights for the Middle East & Africa Structural Heart provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Structural Heart Report Scope

Middle East & Africa Structural Heart Regional Insights

The geographic scope of the Middle East & Africa Structural Heart refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Structural Heart Market Segmentation

The Middle East & Africa structural heart market is segmented into product, procedure, end user, and country.

Based on product, the Middle East & Africa structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Middle East & Africa structural heart market in 2022.

Based on procedure, the Middle East & Africa structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Middle East & Africa structural heart market in 2022.

Based on end user, the Middle East & Africa Structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the Middle East & Africa structural heart market in 2022.

Based on country, the Middle East & Africa structural heart market is segmented into the Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa structural heart market in 2022.   

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, and Edwards Lifesciences Corp are some of the leading companies operating in the Middle East & Africa structural heart market.